E. Ayhan Et Al. , "COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases," International Journal of Dermatology , vol.60, no.2, pp.253-254, 2021
Ayhan, E. Et Al. 2021. COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases. International Journal of Dermatology , vol.60, no.2 , 253-254.
Ayhan, E., Öztürk, M., An, İ., & Bekçİbaşi, M., (2021). COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases. International Journal of Dermatology , vol.60, no.2, 253-254.
Ayhan, Erhan Et Al. "COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases," International Journal of Dermatology , vol.60, no.2, 253-254, 2021
Ayhan, Erhan Et Al. "COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases." International Journal of Dermatology , vol.60, no.2, pp.253-254, 2021
Ayhan, E. Et Al. (2021) . "COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases." International Journal of Dermatology , vol.60, no.2, pp.253-254.
@article{article, author={Erhan Ayhan Et Al. }, title={COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases}, journal={International Journal of Dermatology}, year=2021, pages={253-254} }